http://media.marketwire.com/attachments/201102/21354_mwupload_524_logo.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=793820&ProfileId=051205&sourceType=1SAN DIEGO, CA -- (Marketwire) -- 08/31/11 -- NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that the Company plans to present at two investor conferences in September.
Michael J. Lambert, Executive Vice President and Chief Financial Officer, is scheduled to present at the Stifel Nicolaus Health Care Conference at the Four Seasons Hotel at 200 Boylston Street in Boston, MA, on Wednesday, September 7, 2011, at 3:15 p.m. ET.
Mr. Lambert is also scheduled to present at the Robert Baird Health Care Conference at The New York Palace Hotel at 455 Madison Avenue in New York, NY, on Thursday, September 8, 2011, at 1:45 p.m. ET.
A live webcast of each of the presentations will be available online from the investor relations page of the Company's corporate website at www.nuvasive.com. After the live webcasts, the presentations will remain available on the website for 30 days.
About NuVasive
NuVasive is a medical device company focused on developing minimally disruptive surgical products and procedures for the spine. The Company is the 5th largest player in the $7.7 billion global spine market.
NuVasive's principal product offering is based on its Maximum Access Surgery, or MAS® platform. The MAS platform combines four categories of products that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: a proprietary software-driven nerve avoidance system; MaXcess®, a unique split-blade retractor system; a wide variety of specialized implants; and several biologic fusion enhancers. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches. Having redefined spine surgery with the MAS platform's lateral approach, known as eXtreme Lateral Interbody Fusion, or XLIF®, NuVasive has built an entire spine franchise.